“merck” Archives

in
Entry Author Date Location
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
With Reverse Merger, Miragen to Go Public, Get $40M Boost From Investors 11/01/16 Boulder/Denver
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer 10/25/16 National
Eli Lilly Commits $15M More to Seattle Institute’s TB Drug Search 10/18/16 Indiana
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Taking Aim at Alexion, Ra Pharma Heads to IPO Queue 10/03/16 Boston
New Rockefeller Prez Takes Stock of “Wildly Underdeveloped” NY Bio Scene 09/27/16 New York
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
As Pfizer Buys, Closes Bind Tx, CEO Hirsch Heads to Agios 08/16/16 Boston
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Heron Gains FDA Support For Nausea Drug After A Year Under Review 08/10/16 San Francisco
Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer 08/05/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Merck, Amgen Invest in Akili as Therapeutic Video Game Moves Ahead 07/20/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
As Purdue Pushes Life Sciences, Foundation Seeks $10M For New Fund 07/18/16 Indiana
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News 07/15/16 National
Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data 07/08/16 Boston
With CF Pact, Moderna and Vertex Aim to Spray mRNA Into the Lungs 07/06/16 Boston
Page 2 of 21 « previous page · next page »